BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem. 2000;275:7862-7869. [PMID: 10713101 DOI: 10.1074/jbc.275.11.7862] [Cited by in Crossref: 367] [Cited by in F6Publishing: 350] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Chakera A, Seeber RM, John AE, Eidne KA, Greaves DR. The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization. Mol Pharmacol 2008;73:1362-70. [DOI: 10.1124/mol.107.040915] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
2 Persani L, Calebiro D, Bonomi M. Technology Insight: modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization. Nat Clin Pract Endocrinol Metab 2007;3:180-90. [PMID: 17237844 DOI: 10.1038/ncpendmet0401] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zou Y, Tan H, Zhao Y, Zhou Y, Cao L. Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells. Oncol Lett 2019;17:1723-31. [PMID: 30675231 DOI: 10.3892/ol.2018.9773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tarakanov AO, Fuxe KG, Borroto-Escuela DO. On the origin of the triplet puzzle of homologies in receptor heteromers: immunoglobulin triplets in different types of receptors. J Mol Neurosci 2012;46:616-21. [PMID: 21932037 DOI: 10.1007/s12031-011-9649-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou F, Filipeanu CM, Duvernay MT, Wu G. Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization. Cell Signal 2006;18:318-27. [PMID: 15961277 DOI: 10.1016/j.cellsig.2005.05.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
6 Casnici C, Lattuada D, Crotta K, Mastrotto C, Franco P, Culler M, Marelli O. Effects of chimeric somatostatin–dopamine molecules on human peripheral blood lymphocytes activation. Journal of Neuroimmunology 2006;179:9-17. [DOI: 10.1016/j.jneuroim.2006.06.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Li M, Li W, Kim HJ, Yao Q, Chen C, Fisher WE. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. Journal of Surgical Research 2004;119:130-7. [DOI: 10.1016/j.jss.2004.03.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
8 Rios C, Jordan B, Gomes I, Devi L. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacology & Therapeutics 2001;92:71-87. [DOI: 10.1016/s0163-7258(01)00160-7] [Cited by in Crossref: 230] [Cited by in F6Publishing: 79] [Article Influence: 11.5] [Reference Citation Analysis]
9 Kumar U, Grant M. Somatostatin and somatostatin receptors. Results Probl Cell Differ 2010;50:137-84. [PMID: 19859675 DOI: 10.1007/400_2009_29] [Cited by in Crossref: 10] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
10 Gigoux V, Fourmy D. Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER. Front Endocrinol (Lausanne) 2013;4:50. [PMID: 23641235 DOI: 10.3389/fendo.2013.00050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
11 Pfeiffer M, Koch T, Schröder H, Laugsch M, Höllt V, Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 2002;277:19762-72. [PMID: 11896051 DOI: 10.1074/jbc.M110373200] [Cited by in Crossref: 189] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
12 Park PS, Wells JW. Monomers and Oligomers of the M 2 Muscarinic Cholinergic Receptor Purified from Sf 9 Cells. Biochemistry 2003;42:12960-71. [DOI: 10.1021/bi034491m] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
13 Kumar U. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus. J Comp Neurol 2007;504:185-205. [PMID: 17626271 DOI: 10.1002/cne.21444] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
14 Tarakanov AO, Fuxe KG. Triplet Puzzle: Homologies of Receptor Heteromers. J Mol Neurosci 2010;41:294-303. [DOI: 10.1007/s12031-009-9313-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
15 Ayiomamitis GD, Notas G, Zaravinos A, Drygiannakis I, Georgiadou M, Sfakianaki O, Mastrodimou N, Thermos K, Kouroumalis E. Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity. Oncoscience 2014;1:457-67. [PMID: 25594044 DOI: 10.18632/oncoscience.58] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
16 Chalabi M, Duluc C, Caron P, Vezzosi D, Guillermet-guibert J, Pyronnet S, Bousquet C. Somatostatin analogs: does pharmacology impact antitumor efficacy? Trends in Endocrinology & Metabolism 2014;25:115-27. [DOI: 10.1016/j.tem.2013.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
17 Wang J, Alvarez R, Roderiquez G, Guan E, Norcross MA. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4. J Cell Biochem 2004;93:753-60. [DOI: 10.1002/jcb.20161] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
18 Li M, Zhang R, Li F, Wang H, Kim HJ, Becnel L, Yao Q, Chen C, Fisher WE. Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue. J Am Coll Surg. 2005;201:571-578. [PMID: 16183496 DOI: 10.1016/j.jamcollsurg.2005.06.089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
19 Milligan G, Ramsay D, Pascal G, Carrillo JJ. GPCR dimerisation. Life Sciences 2003;74:181-8. [DOI: 10.1016/j.lfs.2003.09.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
20 Tarakanov AO, Fuxe KG, Borroto-Escuela DO. Integrin triplets of marine sponges in human D2 receptor heteromers. J Recept Signal Transduct Res 2012;32:202-8. [PMID: 22712841 DOI: 10.3109/10799893.2012.692119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
21 Aourz N, Portelli J, Coppens J, De Bundel D, Di Giovanni G, Van Eeckhaut A, Michotte Y, Smolders I. Cortistatin-14 mediates its anticonvulsant effects via sst2 and sst3 but not ghrelin receptors. CNS Neurosci Ther 2014;20:662-70. [PMID: 24685142 DOI: 10.1111/cns.12259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
22 Botta J, Appelhans J, Mccormick PJ. Continuing challenges in targeting oligomeric GPCR-based drugs. Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors. Elsevier; 2020. pp. 213-45. [DOI: 10.1016/bs.pmbts.2019.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Latif R, Graves P, Davies TF. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem 2002;277:45059-67. [PMID: 12223484 DOI: 10.1074/jbc.M206693200] [Cited by in Crossref: 80] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
24 Mellado M, Martínez-A C, Rodríguez-Frade JM. Analysis of G-protein-coupled receptor dimerization following chemokine signaling. Methods 2002;27:349-57. [PMID: 12217651 DOI: 10.1016/s1046-2023(02)00093-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
25 Saveanu A, Gunz G, Dufour H, Caron P, Fina F, Ouafik L, Culler MD, Moreau JP, Enjalbert A, Jaquet P. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. J Clin Endocrinol Metab 2001;86:140-5. [PMID: 11231991 DOI: 10.1210/jcem.86.1.7099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 24] [Article Influence: 0.1] [Reference Citation Analysis]
26 Pavan B, Fiorini S, Dal Monte M, Lunghi L, Biondi C, Bagnoli P, Cervia D. Somatostatin coupling to adenylyl cyclase activity in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol. 2004;370:91-98. [PMID: 15309377 DOI: 10.1007/s00210-004-0950-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
27 Ecke D, Hanck T, Tulapurkar ME, Schäfer R, Kassack M, Stricker R, Reiser G. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J 2008;409:107-16. [PMID: 17824841 DOI: 10.1042/BJ20070671] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
28 Mercier J, Salahpour A, Angers S, Breit A, Bouvier M. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer. Journal of Biological Chemistry 2002;277:44925-31. [DOI: 10.1074/jbc.m205767200] [Cited by in Crossref: 383] [Cited by in F6Publishing: 148] [Article Influence: 20.2] [Reference Citation Analysis]
29 Stengel A, Goebel-Stengel M, Wang L, Luckey A, Hu E, Rivier J, Taché Y. Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol Motil 2011;23:e294-308. [PMID: 21569179 DOI: 10.1111/j.1365-2982.2011.01721.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
30 Wang X, Yang J, Norman M, Magnusson J, Demayo F, Brunicardi F. SSTR5 ablation in islet results in alterations in glucose homeostasis in mice. FEBS Letters 2005;579:3107-14. [DOI: 10.1016/j.febslet.2005.04.069] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
31 Werry TD, Wilkinson GF, Willars GB. Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem J 2003;374:281-96. [PMID: 12790797 DOI: 10.1042/BJ20030312] [Cited by in Crossref: 129] [Cited by in F6Publishing: 116] [Article Influence: 7.2] [Reference Citation Analysis]
32 Conway BR, Demarest KT. The Use of Biosensors to Study GPCR Function: Applications for High-Content Screening. Receptors and Channels 2011;8:331-41. [DOI: 10.3109/10606820214641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Organ LE, Raphael RM. Application of fluorescence recovery after photobleaching to study prestin lateral mobility in the human embryonic kidney cell. J Biomed Opt 2007;12:021003. [DOI: 10.1117/1.2715202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
34 Dasgupta P. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther. 2004;102:61-85. [PMID: 15056499 DOI: 10.1016/j.pharmthera.2004.02.002] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 6.4] [Reference Citation Analysis]
35 Hansen JL, Sheikh SP. Functional consequences of 7TM receptor dimerization. European Journal of Pharmaceutical Sciences 2004;23:301-17. [DOI: 10.1016/j.ejps.2004.08.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
36 Gazi L, López-giménez JF, Rüdiger MP, Strange PG. Constitutive oligomerization of human D 2 dopamine receptors expressed in Spodoptera frugiperda 9 ( Sf9 ) and in HEK293 cells: Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer. European Journal of Biochemistry 2003;270:3928-38. [DOI: 10.1046/j.1432-1033.2003.03773.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
37 Jung Y, Oh SH, Zheng D, Shupe TD, Witek RP, Petersen BE. A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells. Lab Invest. 2006;86:477-489. [PMID: 16534498 DOI: 10.1038/labinvest.3700410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
38 Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006;17:1733-1742. [PMID: 16801334 DOI: 10.1093/annonc/mdl105] [Cited by in Crossref: 194] [Cited by in F6Publishing: 167] [Article Influence: 12.9] [Reference Citation Analysis]
39 Luque RM, Ibáñez-Costa A, Neto LV, Taboada GF, Hormaechea-Agulla D, Kasuki L, Venegas-Moreno E, Moreno-Carazo A, Gálvez MÁ, Soto-Moreno A, Kineman RD, Culler MD, Gahete MD, Gadelha MR, Castaño JP. Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas. Cancer Lett 2015;359:299-306. [PMID: 25637790 DOI: 10.1016/j.canlet.2015.01.037] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
40 Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends in Pharmacological Sciences 2005;26:131-7. [DOI: 10.1016/j.tips.2005.01.004] [Cited by in Crossref: 342] [Cited by in F6Publishing: 328] [Article Influence: 21.4] [Reference Citation Analysis]
41 Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E, Patel YC. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci U S A 2002;99:3294-9. [PMID: 11880655 DOI: 10.1073/pnas.042705099] [Cited by in Crossref: 128] [Cited by in F6Publishing: 116] [Article Influence: 6.7] [Reference Citation Analysis]
42 Maudsley S, Martin B, Luttrell LM. The origins of diversity and specificity in g protein-coupled receptor signaling. J Pharmacol Exp Ther 2005;314:485-94. [PMID: 15805429 DOI: 10.1124/jpet.105.083121] [Cited by in Crossref: 138] [Cited by in F6Publishing: 137] [Article Influence: 8.6] [Reference Citation Analysis]
43 Siddiquee K, Hampton J, McAnally D, May L, Smith L. The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition. Br J Pharmacol 2013;168:1104-17. [PMID: 22935142 DOI: 10.1111/j.1476-5381.2012.02192.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 12.0] [Reference Citation Analysis]
44 Thodou E, Kontogeorgos G, Theodossiou D, Pateraki M. Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas. J Clin Pathol 2006;59:274-9. [PMID: 16505278 DOI: 10.1136/jcp.2005.026914] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
45 Ng SY, Lee LT, Chow BK. Receptor oligomerization: from early evidence to current understanding in class B GPCRs. Front Endocrinol (Lausanne) 2012;3:175. [PMID: 23316183 DOI: 10.3389/fendo.2012.00175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
46 Kaemmerer D, Specht E, Sänger J, Wirtz RM, Sayeg M, Schulz S, Lupp A. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. J Clin Endocrinol Metab 2015;100:831-40. [PMID: 25494861 DOI: 10.1210/jc.2014-2699] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
47 Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2003;2:999-1017. [PMID: 14654798 DOI: 10.1038/nrd1255] [Cited by in Crossref: 379] [Cited by in F6Publishing: 345] [Article Influence: 22.3] [Reference Citation Analysis]
48 Filizola M, Weinstein H. Structural models for dimerization of G-protein coupled receptors: The opioid receptor homodimers. Biopolymers 2002;66:317-25. [DOI: 10.1002/bip.10311] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
49 Zou S, Somvanshi RK, Kumar U. Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1. Neuroscience 2017;340:218-31. [PMID: 27984180 DOI: 10.1016/j.neuroscience.2016.10.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
50 Eberle AN, Mild G, Froidevaux S. Receptor-Mediated Tumor Targeting with Radiopeptides. Part 1. General Concepts and Methods: Applications to Somatostatin Receptor-Expressing Tumors. Journal of Receptors and Signal Transduction 2004;24:319-455. [DOI: 10.1081/rrs-200040939] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 Herrick-Davis K, Grinde E, Weaver BA. Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment. Eur J Pharmacol 2007;568:45-53. [PMID: 17507008 DOI: 10.1016/j.ejphar.2007.04.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
52 Massoud TF, Paulmurugan R, Gambhir SS. Molecular imaging of homodimeric protein-protein interactions in living subjects. FASEB J 2004;18:1105-7. [PMID: 15132989 DOI: 10.1096/fj.03-1128fje] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
53 Msaouel P, Galanis E, Koutsilieris M. Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology. Expert Opin Investig Drugs 2009;18:1297-316. [PMID: 19678799 DOI: 10.1517/13543780903176399] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
54 Bates B, Xie Y, Taylor N, Johnson J, Wu L, Kwak S, Blatcher M, Gulukota K, Paulsen JE. Characterization of mGluR5R, a novel, metabotropic glutamate receptor 5-related gene. Molecular Brain Research 2002;109:18-33. [DOI: 10.1016/s0169-328x(02)00458-8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
55 Ren S, Kim S, Taylor J, Dong J, Moreau J, Culler MD, Melmed S. Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand. The Journal of Clinical Endocrinology & Metabolism 2003;88:5414-21. [DOI: 10.1210/jc.2003-030302] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
56 Herrick-Davis K, Weaver BA, Grinde E, Mazurkiewicz JE. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 2006;281:27109-16. [PMID: 16857671 DOI: 10.1074/jbc.M604390200] [Cited by in Crossref: 94] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
57 Purisai MG, Sands SA, Davis TD, Price JL, Chronwall BM. GABAB receptor subunit mRNAs are differentially regulated in pituitary melanotropes during development and detection of functioning receptors coincides with completion of innervation. Int J Dev Neurosci 2005;23:315-26. [PMID: 15927755 DOI: 10.1016/j.ijdevneu.2005.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
58 Srirajaskanthan R, Toumpanakis C, Meyer T, Caplin ME. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Aliment Pharmacol Ther. 2009;29:1143-1154. [PMID: 19298583 DOI: 10.1111/j.1365-2036.2009.03988.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
59 Goodyer C, Grigorakis S, Patel Y, Kumar U. Developmental changes in the expression of somatostatin receptors (1–5) in the brain, hypothalamus, pituitary and spinal cord of the human fetus. Neuroscience 2004;125:441-8. [DOI: 10.1016/j.neuroscience.2004.02.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
60 Yang S, Parkington HC, Blake AD, Keating DJ, Chen C. Somatostatin Increases Voltage-Gated K+ Currents in GH3 Cells through Activation of Multiple Somatostatin Receptors. Endocrinology 2005;146:4975-84. [DOI: 10.1210/en.2005-0696] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
61 Patel RC, Lange DC, Patel YC. Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes. Methods 2002;27:340-8. [DOI: 10.1016/s1046-2023(02)00092-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
62 Wang CI, Lewis RJ. Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem Pharmacol 2013;85:153-62. [PMID: 22975406 DOI: 10.1016/j.bcp.2012.09.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
63 Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with  2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation. Proceedings of the National Academy of Sciences 2001;98:343-8. [DOI: 10.1073/pnas.98.1.343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
64 Alberich Jordà M, Rayman N, Tas M, Verbakel SE, Battista N, van Lom K, Löwenberg B, Maccarrone M, Delwel R. The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. Blood 2004;104:526-34. [PMID: 15039279 DOI: 10.1182/blood-2003-12-4357] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
65 Shimon I. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs. Endocrine 2003;20:265-9. [PMID: 12721506 DOI: 10.1385/ENDO:20:3:265] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
66 Colao A, Auriemma RS, Lombardi G, Pivonello R. Resistance to somatostatin analogs in acromegaly. Endocr Rev 2011;32:247-71. [PMID: 21123741 DOI: 10.1210/er.2010-0002] [Cited by in Crossref: 165] [Cited by in F6Publishing: 148] [Article Influence: 15.0] [Reference Citation Analysis]
67 Barbieri F, Pattarozzi A, Gatti M, Aiello C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD, Florio T. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. Am J Physiol Endocrinol Metab 2009;297:E1078-88. [PMID: 19706788 DOI: 10.1152/ajpendo.00292.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
68 Pittaluga A, Feligioni M, Longordo F, Arvigo M, Raiteri M. Somatostatin-Induced Activation and Up-Regulation of N -Methyl-d-aspartate Receptor Function: Mediation through Calmodulin-Dependent Protein Kinase II, Phospholipase C, Protein Kinase C, and Tyrosine Kinase in Hippocampal Noradrenergic Nerve Endings. J Pharmacol Exp Ther 2005;313:242-9. [DOI: 10.1124/jpet.104.079590] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
69 Park P, Sum CS, Hampson DR, Van Tol HH, Wells JW. Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells. European Journal of Pharmacology 2001;421:11-22. [DOI: 10.1016/s0014-2999(01)00998-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
70 Dal Monte M, Latina V, Cupisti E, Bagnoli P. Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:481-94. [DOI: 10.1007/s00210-012-0735-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
71 Durán-Prado M, Malagón MM, Gracia-Navarro F, Castaño JP. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol 2008;286:63-8. [PMID: 18242821 DOI: 10.1016/j.mce.2007.12.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
72 Wager-Miller J, Westenbroek R, Mackie K. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem Phys Lipids 2002;121:83-9. [PMID: 12505693 DOI: 10.1016/s0009-3084(02)00151-2] [Cited by in Crossref: 101] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
73 Bockaert J, Claeysen S, Bécamel C, Sylvie P, Dumuis A. G Protein-Coupled Receptors: Dominant Players in Cell–Cell Communication. A Survey of Cell Biology. Elsevier; 2002. pp. 63-136e. [DOI: 10.1016/s0074-7696(01)12004-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
74 Kim SK, Jacobson KA. Computational prediction of homodimerization of the A3 adenosine receptor. J Mol Graph Model 2006;25:549-61. [PMID: 16781879 DOI: 10.1016/j.jmgm.2006.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
75 Breit A, Gagnidze K, Devi LA, Lagacé M, Bouvier M. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Mol Pharmacol 2006;70:686-96. [PMID: 16682504 DOI: 10.1124/mol.106.022897] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
76 Wang XP, Norman M, Yang J, Liu SH, Magnusson J, DeMayo FJ, Brunicardi FC. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice. J Surg Res 2005;129:64-72. [PMID: 16026801 DOI: 10.1016/j.jss.2005.05.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
77 Ramı́rez JL, Grant M, Norman M, Wang X, Moldovan S, Mayo F, Brunicardi C, Kumar U. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas. Molecular and Cellular Endocrinology 2004;221:105-19. [DOI: 10.1016/j.mce.2004.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
78 Csaba Z, Dournaud P. Cellular biology of somatostatin receptors. Neuropeptides 2001;35:1-23. [PMID: 11346306 DOI: 10.1054/npep.2001.0848] [Cited by in Crossref: 169] [Cited by in F6Publishing: 158] [Article Influence: 8.5] [Reference Citation Analysis]
79 Sorkin A, Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 2002;3:600-14. [PMID: 12154371 DOI: 10.1038/nrm883] [Cited by in Crossref: 629] [Cited by in F6Publishing: 609] [Article Influence: 33.1] [Reference Citation Analysis]
80 Choi RC, Simon J, Tsim KW, Barnard EA. Constitutive and agonist-induced dimerizations of the P2Y1 receptor: relationship to internalization and scaffolding. J Biol Chem 2008;283:11050-63. [PMID: 18270199 DOI: 10.1074/jbc.M709266200] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
81 Møller LN, Stidsen CE, Hartmann B, Holst JJ. Somatostatin receptors. Biochim Biophys Acta. 2003;1616:1-84. [PMID: 14507421 DOI: 10.1016/s0005-2736(03)00235-9] [Cited by in Crossref: 230] [Cited by in F6Publishing: 83] [Article Influence: 12.8] [Reference Citation Analysis]
82 Froidevaux S, Eberle AN. Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers. 2002;66:161-183. [PMID: 12385036 DOI: 10.1002/bip.10256] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 5.1] [Reference Citation Analysis]
83 Berardi R, Morgese F, Torniai M, Savini A, Partelli S, Rinaldi S, Caramanti M, Ferrini C, Falconi M, Cascinu S. Medical treatment for gastro-entero-pancreatic neuroendocrine tumours. World J Gastrointest Oncol 2016; 8(4): 389-401 [PMID: 27096034 DOI: 10.4251/wjgo.v8.i4.389] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
84 Rivera JA, Alturaihi H, Kumar U. Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells. J Carcinog 2005;4:10. [PMID: 16018813 DOI: 10.1186/1477-3163-4-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
85 Hannon JP, Bruns C, Weckbecker G, Hoyer D. Somatostatin Receptor Gene Family - Subtype Selectivity for Ligand Binding. In: Srikant CB, editor. Somatostatin. Boston: Kluwer Academic Publishers; 2004. pp. 81-106. [DOI: 10.1007/1-4020-8033-6_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Gardette R, Petit F, Peineau S, Lanneau C, Epelbaum J. Coexpression of Multiple Somatostatin Receptors in Individual Cells. In: Srikant CB, editor. Somatostatin. Boston: Kluwer Academic Publishers; 2004. pp. 123-42. [DOI: 10.1007/1-4020-8033-6_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Grant M, Collier B, Kumar U. Agonist-dependent Dissociation of Human Somatostatin Receptor 2 Dimers. Journal of Biological Chemistry 2004;279:36179-83. [DOI: 10.1074/jbc.m407310200] [Cited by in Crossref: 71] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
88 Guillermet-Guibert J, Lahlou H, Pyronnet S, Bousquet C, Susini C. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects. Best Pract Res Clin Gastroenterol 2005;19:535-51. [PMID: 16183526 DOI: 10.1016/j.bpg.2005.03.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
89 Cervia D, Nunn C, Fehlmann D, Langenegger D, Schuepbach E, Hoyer D. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs. Br J Pharmacol 2003;139:109-21. [PMID: 12746229 DOI: 10.1038/sj.bjp.0705235] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
90 Grant M, Alturaihi H, Jaquet P, Collier B, Kumar U. Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol Endocrinol 2008;22:2278-92. [PMID: 18653781 DOI: 10.1210/me.2007-0334] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
91 Reubi JC, Eisenwiener KP, Rink H, Waser B, Macke HR. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur J Pharmacol. 2002;456:45-49. [PMID: 12450568 DOI: 10.1016/S0014-2999(02)02651-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
92 Tsai S, Hong C. Dopamine receptor hetero-oligomerization in the pathogenesis of schizophrenia: qualitative as opposed to quantitative notions of dopaminergic receptors. Schizophrenia Research 2003;63:197-8. [DOI: 10.1016/s0920-9964(02)00436-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Gillam MP, Ku CR, Lee YJ, Kim J, Kim SH, Lee SJ, Hwang B, Koo J, Kineman RD, Kiyokawa H, Lee EJ. Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling. J Endocr Soc 2017;1:78-95. [PMID: 29264469 DOI: 10.1210/js.2016-1004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
94 Joseph IM, Kirschner D. A model for the study of Helicobacter pylori interaction with human gastric acid secretion. J Theor Biol. 2004;228:55-80. [PMID: 15064083 DOI: 10.1016/j.jtbi.2003.12.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
95 Hiller C, Kühhorn J, Gmeiner P. Class A G-Protein-Coupled Receptor (GPCR) Dimers and Bivalent Ligands. J Med Chem 2013;56:6542-59. [DOI: 10.1021/jm4004335] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 10.0] [Reference Citation Analysis]
96 Jensen AA, Hansen JL, Sheikh SP, Bräuner-osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET): Homodimerization of CaR in living cells. European Journal of Biochemistry 2002;269:5076-87. [DOI: 10.1046/j.1432-1033.2002.03218.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
97 Merten N, Beck-Sickinger AG. Molecular ligand-receptor interaction of the NPY/PP peptide family. EXS 2006;:35-62. [PMID: 16382996 DOI: 10.1007/3-7643-7417-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
98 Franco R, Lluis C, Canela EI, Mallol J, Agnati L, Casadó V, Ciruela F, Ferré S, Fuxe K. Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J Neural Transm (Vienna) 2007;114:93-104. [PMID: 17024327 DOI: 10.1007/s00702-006-0566-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
99 Pétrin D, Hébert TE. Imaging-Based Approaches to Understanding G Protein-Coupled Receptor Signalling Complexes. In: Luttrell LM, Ferguson SSG, editors. Signal Transduction Protocols. Totowa: Humana Press; 2011. pp. 37-60. [DOI: 10.1007/978-1-61779-160-4_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
100 Rindi G, Wiedenmann B. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat Rev Endocrinol 2020;16:590-607. [PMID: 32839579 DOI: 10.1038/s41574-020-0391-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
101 Cornea A, Janovick JA, Maya-Núñez G, Conn PM. Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J Biol Chem 2001;276:2153-8. [PMID: 11035030 DOI: 10.1074/jbc.M007850200] [Cited by in Crossref: 105] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
102 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 35.0] [Reference Citation Analysis]
103 Manser RC, Houghton FD. Ca2+ -linked upregulation and mitochondrial production of nitric oxide in the mouse preimplantation embryo. J Cell Sci 2006;119:2048-55. [PMID: 16638811 DOI: 10.1242/jcs.02927] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
104 Van Op den Bosch J, Adriaensen D, Van Nassauw L, Timmermans JP. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul Pept. 2009;156:1-8. [PMID: 19362110 DOI: 10.1016/j.regpep.2009.04.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
105 Perron A, Sharif N, Sarret P, Stroh T, Beaudet A. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization. Biochem Biophys Res Commun 2007;353:582-90. [PMID: 17188644 DOI: 10.1016/j.bbrc.2006.12.062] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
106 Bigiani A, Petrucci C, Ghiaroni V, Dal Monte M, Cozzi A, Kreienkamp HJ, Richter D, Bagnoli P. Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res. 2004;1025:177-185. [PMID: 15464758 DOI: 10.1016/j.brainres.2004.07.083] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
107 Zatelli MC, Piccin D, Ambrosio MR, Bondanelli M, Uberti ECD. Antiproliferative effects of somatostatin analogs in pituitary adenomas. Pituitary 2006;9:27-34. [DOI: 10.1007/s11102-006-7822-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
108 Savi P, Zachayus JL, Delesque-Touchard N, Labouret C, Hervé C, Uzabiaga MF, Pereillo JM, Culouscou JM, Bono F, Ferrara P, Herbert JM. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A 2006;103:11069-74. [PMID: 16835302 DOI: 10.1073/pnas.0510446103] [Cited by in Crossref: 221] [Cited by in F6Publishing: 200] [Article Influence: 14.7] [Reference Citation Analysis]
109 Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K. Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons. Pharmacol Rev 2003;55:509-50. [DOI: 10.1124/pr.55.3.2] [Cited by in Crossref: 233] [Cited by in F6Publishing: 228] [Article Influence: 12.9] [Reference Citation Analysis]
110 Schmid JA, Scholze P, Kudlacek O, Freissmuth M, Singer EA, Sitte HH. Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living Cells. Journal of Biological Chemistry 2001;276:3805-10. [DOI: 10.1074/jbc.m007357200] [Cited by in Crossref: 137] [Cited by in F6Publishing: 67] [Article Influence: 6.9] [Reference Citation Analysis]
111 Cheung TC, Hearn JP. Development of a baculovirus-based fluorescence resonance energy transfer assay for measuring protein-protein interaction. Eur J Biochem 2003;270:4973-81. [PMID: 14653823 DOI: 10.1046/j.1432-1033.2003.03899.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
112 Ferone D, Arvigo M, Semino C, Jaquet P, Saveanu A, Taylor JE, Moreau JP, Culler MD, Albertelli M, Minuto F, Barreca A. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. Am J Physiol Endocrinol Metab 2005;289:E1044-50. [PMID: 16046458 DOI: 10.1152/ajpendo.00209.2005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
113 Neverova NV, Saywell SA, Nashold LJ, Mitchell GS, Feldman JL. Episodic stimulation of alpha1-adrenoreceptors induces protein kinase C-dependent persistent changes in motoneuronal excitability. J Neurosci 2007;27:4435-42. [PMID: 17442828 DOI: 10.1523/JNEUROSCI.2803-06.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
114 Stengel A, Rivier J, Taché Y. Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes. Curr Pharm Des 2013;19:98-105. [PMID: 22950508 DOI: 10.2174/13816128130114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
115 Herrick-Davis K, Grinde E, Lindsley T, Cowan A, Mazurkiewicz JE. Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers. J Biol Chem 2012;287:23604-14. [PMID: 22593582 DOI: 10.1074/jbc.M112.350249] [Cited by in Crossref: 68] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
116 Tarakanov AO, Fuxe KG. The triplet puzzle of homologies in receptor heteromers exists also in other types of protein-protein interactions. J Mol Neurosci 2011;44:173-7. [PMID: 21416272 DOI: 10.1007/s12031-011-9511-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
117 Lecca D, Abbracchio MP. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs. Neurochem Int 2008;52:339-51. [PMID: 17884255 DOI: 10.1016/j.neuint.2007.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
118 Gripentrog JM, Kantele KP, Jesaitis AJ, Miettinen HM. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor. J Immunol 2003;171:3187-93. [PMID: 12960347 DOI: 10.4049/jimmunol.171.6.3187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
119 Gomes I, Fujita W, Chandrakala MV, Devi LA. Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse. Prog Mol Biol Transl Sci 2013;117:207-65. [PMID: 23663971 DOI: 10.1016/B978-0-12-386931-9.00009-X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
120 Cozzi R, Attanasio R. Octreotide long-acting repeatable for acromegaly. Expert Rev Clin Pharmacol 2012;5:125-43. [PMID: 22390555 DOI: 10.1586/ecp.12.4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
121 Ferone D. Neuroendocrine-Immune Interactions: The Role of Cortistatin/Somatostatin System. Annals of the New York Academy of Sciences 2006;1069:129-44. [DOI: 10.1196/annals.1351.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
122 Kenworthy AK. Photobleaching FRET Microscopy. Molecular Imaging. Elsevier; 2005. pp. 146-64. [DOI: 10.1016/b978-019517720-6.50017-1] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
123 Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, Hall RA. Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. J Biol Chem 2003;278:10770-7. [PMID: 12529373 DOI: 10.1074/jbc.M207968200] [Cited by in Crossref: 102] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
124 George SR, O'dowd BF, Lee SP. G-Protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 2002;1:808-20. [DOI: 10.1038/nrd913] [Cited by in Crossref: 448] [Cited by in F6Publishing: 430] [Article Influence: 23.6] [Reference Citation Analysis]
125 Milligan G, Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J 2005;272:2914-25. [PMID: 15955052 DOI: 10.1111/j.1742-4658.2005.04731.x] [Cited by in Crossref: 167] [Cited by in F6Publishing: 162] [Article Influence: 10.4] [Reference Citation Analysis]
126 Young SF, Griffante C, Aguilera G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell Mol Neurobiol 2007;27:439-61. [PMID: 17318384 DOI: 10.1007/s10571-006-9135-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
127 Giustina A, Mazziotti G, Maffezzoni F, Amoroso V, Berruti A. Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. Expert Opinion on Investigational Drugs 2014;23:1619-35. [DOI: 10.1517/13543784.2014.942728] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
128 Gastambide F, Lepousez G, Viollet C, Loudes C, Epelbaum J, Guillou JL. Cooperation between hippocampal somatostatin receptor subtypes 4 and 2: functional relevance in interactive memory systems. Hippocampus 2010;20:745-57. [PMID: 19623609 DOI: 10.1002/hipo.20680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
129 Clerc P, Leung-Theung-Long S, Wang TC, Dockray GJ, Bouisson M, Delisle MB, Vaysse N, Pradayrol L, Fourmy D, Dufresne M. Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology 2002;122:428-37. [PMID: 11832457 DOI: 10.1053/gast.2002.30984] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
130 Sharif N, Gendron L, Wowchuk J, Sarret P, Mazella J, Beaudet A, Stroh T. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2. Endocrinology 2007;148:2095-105. [PMID: 17272399 DOI: 10.1210/en.2006-1266] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
131 Buchan AM, Lin CY, Choi J, Barber DL. Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration. J Biol Chem 2002;277:28431-8. [PMID: 12045195 DOI: 10.1074/jbc.M201261200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
132 Rebois RV, Hébert TE. Protein Complexes Involved in Heptahelical Receptor-Mediated Signal Transduction. Receptors and Channels 2011;9:169-94. [DOI: 10.3109/10606820308243] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
133 Laffray S, Bouali-Benazzouz R, Papon MA, Favereaux A, Jiang Y, Holm T, Spriet C, Desbarats P, Fossat P, Le Feuvre Y, Decossas M, Héliot L, Langel U, Nagy F, Landry M. Impairment of GABAB receptor dimer by endogenous 14-3-3ζ in chronic pain conditions. EMBO J 2012;31:3239-51. [PMID: 22692127 DOI: 10.1038/emboj.2012.161] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
134 Stanasila L, Perez JB, Vogel H, Cotecchia S. Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 2003;278:40239-51. [PMID: 12888550 DOI: 10.1074/jbc.M306085200] [Cited by in Crossref: 132] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
135 Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C. Antitumor effects of somatostatin. Mol Cell Endocrinol. 2008;286:230-237. [PMID: 18359151 DOI: 10.1016/j.mce.2008.02.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 8.0] [Reference Citation Analysis]
136 corleto VD, severi C, romano G, tattoli I, weber HC, stridsberg M, rindi G, campanini N, tomassoni F, pagotto U, coy DH, jensen RT, delle fave G. Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 2006;18:217-25. [DOI: 10.1111/j.1365-2982.2005.00752.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
137 Leu FP, Nandi M. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line. Pancreas 2010;39:1155-66. [PMID: 20531241 DOI: 10.1097/MPA.0b013e3181de8c05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
138 Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci. 2002;16:843-849. [PMID: 12372020 DOI: 10.1046/j.1460-9568.2002.02146.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
139 Giguère V, Gallant MA, de Brum-Fernandes AJ, Parent JL. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor. Eur J Pharmacol 2004;494:11-22. [PMID: 15194446 DOI: 10.1016/j.ejphar.2004.04.041] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
140 Cai C, Li H, Kangasniemi A, Pihlajamaa T, Von Ossowski L, Kerkelä K, Schulz S, Rivera C, Keinänen K. Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics. Neuroscience 2008;157:833-43. [PMID: 18951956 DOI: 10.1016/j.neuroscience.2008.09.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
141 Gouldson PR, Dean MK, Snell CR, Bywater RP, Gkoutos G, Reynolds CA. Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. Protein Engineering, Design and Selection 2001;14:759-67. [DOI: 10.1093/protein/14.10.759] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
142 Casnici C, Lattuada D, Crotta K, Truzzi MC, Corradini C, Ingegnoli F, Tonna N, Bianco F, Marelli O. Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes. Inflammation 2018;41:1648-60. [DOI: 10.1007/s10753-018-0808-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
143 Spary EJ, Maqbool A, Batten TF. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. J Chem Neuroanat 2008;35:49-66. [PMID: 17646081 DOI: 10.1016/j.jchemneu.2007.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
144 Ke R, Lok SIS, Singh K, Chow BKC, Lee LTO. GIP receptor suppresses PAC1receptor-mediated neuronal differentiation via formation of a receptor heterocomplex. J Neurochem 2021;157:1850-60. [PMID: 33078390 DOI: 10.1111/jnc.15220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 de Lecea L. Cortistatin--functions in the central nervous system. Mol Cell Endocrinol 2008;286:88-95. [PMID: 18374474 DOI: 10.1016/j.mce.2007.12.014] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
146 Faklaris O, Cottet M, Falco A, Villier B, Laget M, Zwier JM, Trinquet E, Mouillac B, Pin JP, Durroux T. Multicolor time-resolved Förster resonance energy transfer microscopy reveals the impact of GPCR oligomerization on internalization processes. FASEB J 2015;29:2235-46. [PMID: 25690655 DOI: 10.1096/fj.14-260059] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
147 Barbieri F, Bajetto A, Pattarozzi A, Gatti M, Würth R, Thellung S, Corsaro A, Villa V, Nizzari M, Florio T. Peptide receptor targeting in cancer: the somatostatin paradigm. Int J Pept 2013;2013:926295. [PMID: 23476673 DOI: 10.1155/2013/926295] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
148 Kroeger KM, Pfleger KD, Eidne KA. G-protein coupled receptor oligomerization in neuroendocrine pathways. Frontiers in Neuroendocrinology 2003;24:254-78. [DOI: 10.1016/j.yfrne.2003.10.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
149 Martin S, Navarro V, Vincent JP, Mazella J. Neurotensin receptor–1 and –3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 2002;123:1135-43. [DOI: 10.1053/gast.2002.36000] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 4.7] [Reference Citation Analysis]
150 Cakir M, Dworakowska D, Grossman A. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. J Cell Mol Med 2010;14:2570-84. [PMID: 20629989 DOI: 10.1111/j.1582-4934.2010.01125.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
151 Milligan G. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. Eur J Pharm Sci 2004;21:397-405. [PMID: 14998570 DOI: 10.1016/j.ejps.2003.11.010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 5.3] [Reference Citation Analysis]
152 Li M, Fisher WE, Kim HJ, Wang X, Brunicardi CF, Chen C, Yao Q. Somatostatin, Somatostatin Receptors, and Pancreatic Cancer. World J Surg 2005;29:293-6. [DOI: 10.1007/s00268-004-7814-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
153 Hofland LJ, Lamberts SW. Somatostatin receptor subtype expression in human tumors. Ann Oncol. 2001;12 Suppl 2:S31-S36. [PMID: 11762349 DOI: 10.1093/annonc/12.suppl_2.s31] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
154 Harikumar KG, Morfis MM, Sexton PM, Miller LJ. Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J Mol Neurosci 2008;36:279-85. [PMID: 18401761 DOI: 10.1007/s12031-008-9060-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
155 Gama L, Wilt SG, Breitwieser GE. Heterodimerization of Calcium Sensing Receptors with Metabotropic Glutamate Receptors in Neurons. Journal of Biological Chemistry 2001;276:39053-9. [DOI: 10.1074/jbc.m105662200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
156 Schulz C, Mathieu R, Kunz U, Mauer UM. Treatment of unresectable skull base meningiomas with somatostatin analogs. Neurosurg Focus 2011;30:E11. [PMID: 21529167 DOI: 10.3171/2011.1.FOCUS111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
157 Masmoudi O, Gandolfo P, Tokay T, Leprince J, Ravni A, Vaudry H, Tonon MC. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J Neurochem 2005;94:561-71. [PMID: 16033415 DOI: 10.1111/j.1471-4159.2005.03076.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
158 Nickolls SA, Maki RA. Dimerization of the melanocortin 4 receptor: A study using bioluminescence resonance energy transfer. Peptides 2006;27:380-7. [DOI: 10.1016/j.peptides.2004.12.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
159 Lavoie C, Mercier J, Salahpour A, Umapathy D, Breit A, Villeneuve L, Zhu W, Xiao R, Lakatta EG, Bouvier M, Hébert TE. β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy. Journal of Biological Chemistry 2002;277:35402-10. [DOI: 10.1074/jbc.m204163200] [Cited by in Crossref: 167] [Cited by in F6Publishing: 65] [Article Influence: 8.8] [Reference Citation Analysis]
160 Stengel A, Rivier J, Taché Y. Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes. Peptides 2013;42:70-7. [PMID: 23287111 DOI: 10.1016/j.peptides.2012.12.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
161 Cervia D, Bagnoli P. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacol Ther 2007;116:322-41. [PMID: 17719647 DOI: 10.1016/j.pharmthera.2007.06.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
162 Somvanshi RK, Billova S, Kharmate G, Rajput PS, Kumar U. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling. Cell Signal 2009;21:1396-414. [PMID: 19426801 DOI: 10.1016/j.cellsig.2009.04.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
163 Ferone D, van Hagen P, Semino C, Dalm V, Barreca A, Colao A, Lamberts S, Minuto F, Hofland L. Somatostatin receptor distribution and function in immune system. Digestive and Liver Disease 2004;36:S68-77. [DOI: 10.1016/j.dld.2003.11.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
164 Stengel A, Goebel-Stengel M, Wang L, Larauche M, Rivier J, Taché Y. Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice. Neurogastroenterol Motil 2011;23:e223-36. [PMID: 21564422 DOI: 10.1111/j.1365-2982.2011.01706.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
165 Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D. Pharmacological profile of somatostatin and cortistatin receptors. Molecular and Cellular Endocrinology 2008;286:26-34. [DOI: 10.1016/j.mce.2007.12.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
166 Prinster SC, Hague C, Hall RA. Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance. Pharmacol Rev 2005;57:289-98. [DOI: 10.1124/pr.57.3.1] [Cited by in Crossref: 278] [Cited by in F6Publishing: 269] [Article Influence: 17.4] [Reference Citation Analysis]
167 Gahete MD, Durán-prado M, Delgado-niebla E, Garrido JJ, Rhodes SJ, García-navarro S, Gracia-navarro F, Malagón MM, Luque RM, Castaño JP. Porcine sst1 can physically interact with other somatostatin receptors, and its expression is regulated by metabolic/inflammatory sensors. American Journal of Physiology-Endocrinology and Metabolism 2014;306:E483-93. [DOI: 10.1152/ajpendo.00587.2013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Glickstein SB, Schmauss C. Dopamine receptor functions: lessions from knockout mice. Pharmacology & Therapeutics 2001;91:63-83. [DOI: 10.1016/s0163-7258(01)00145-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
169 Park S, Jiang H, Zhang H, Smith RG. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci U S A 2012;109:19003-8. [PMID: 23112170 DOI: 10.1073/pnas.1209590109] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
170 Stengel A, Taché Y. Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications. Front Endocrinol (Lausanne) 2012;3:178. [PMID: 23335913 DOI: 10.3389/fendo.2012.00178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
171 Kiseljak-Vassiliades K, Xu M, Mills TS, Smith EE, Silveira LJ, Lillehei KO, Kerr JM, Kleinschmidt-DeMasters BK, Wierman ME. Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors. Mol Cell Endocrinol 2015;417:73-83. [PMID: 26391562 DOI: 10.1016/j.mce.2015.09.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
172 Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001;2:274-86. [DOI: 10.1038/35067575] [Cited by in Crossref: 495] [Cited by in F6Publishing: 471] [Article Influence: 24.8] [Reference Citation Analysis]
173 Strowski MZ, Blake AD. Function and expression of somatostatin receptors of the endocrine pancreas. Mol Cell Endocrinol 2008;286:169-79. [PMID: 18375050 DOI: 10.1016/j.mce.2008.02.007] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
174 Paragliola RM, Corsello SM, Salvatori R. Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance. Pituitary 2017;20:109-15. [PMID: 27778296 DOI: 10.1007/s11102-016-0768-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
175 Hansson J, Bjartell A, Gadaleanu V, Dizeyi N, Abrahamsson PA. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer. Prostate. 2002;53:50-59. [PMID: 12210479 DOI: 10.1002/pros.10121] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
176 Zou S, Kumar U. Somatostatin and cannabinoid receptors crosstalk in protection of huntingtin knock-in striatal neuronal cells in response to quinolinic acid. Neurochemistry International 2019;129:104518. [DOI: 10.1016/j.neuint.2019.104518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
177 Scholze P, Freissmuth M, Sitte HH. Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J Biol Chem 2002;277:43682-90. [PMID: 12223478 DOI: 10.1074/jbc.M205602200] [Cited by in Crossref: 90] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
178 Ludvigsen E. Somatostatin Receptor Expression and Biological Functions in Endocrine Pancreatic Cells. Upsala Journal of Medical Sciences 2009;112:1-20. [DOI: 10.3109/2000-1967-091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
179 Cheng Z, Harikumar KG, Holicky EL, Miller LJ. Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth. Journal of Biological Chemistry 2003;278:52972-9. [DOI: 10.1074/jbc.m310090200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
180 Klco JM, Lassere TB, Baranski TJ. C5a Receptor Oligomerization. Journal of Biological Chemistry 2003;278:35345-53. [DOI: 10.1074/jbc.m305606200] [Cited by in Crossref: 91] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
181 Hannon JP, Langenegger D, Waser B, Hoyer D, Reubi J. Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors. European Journal of Pharmacology 2001;426:165-73. [DOI: 10.1016/s0014-2999(01)01223-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Wallace Fitzsimons SE, Chruścicka B, Druelle C, Stamou P, Nally K, Dinan TG, Cryan JF, Schellekens H. A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling. Neuropharmacology 2019;152:90-101. [DOI: 10.1016/j.neuropharm.2018.12.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
183 Breitwieser GE. G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling. Circulation Research 2004;94:17-27. [DOI: 10.1161/01.res.0000110420.68526.19] [Cited by in Crossref: 134] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
184 Dalm VA, Hofland LJ, Lamberts SW. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field. Mol Cell Endocrinol 2008;286:262-77. [PMID: 17942217 DOI: 10.1016/j.mce.2007.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
185 Jennes L, Conn PM. Gonadotropin-Releasing Hormone. Hormones, Brain and Behavior. Elsevier; 2002. pp. 51-XXV. [DOI: 10.1016/b978-012532104-4/50063-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
186 Gastambide F, Viollet C, Lepousez G, Epelbaum J, Guillou JL. Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies. Psychopharmacology (Berl) 2009;202:153-63. [PMID: 18521573 DOI: 10.1007/s00213-008-1204-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
187 George Cisar EA, Geisinger E, Muir TW, Novick RP. Symmetric signalling within asymmetric dimers of the Staphylococcus aureus receptor histidine kinase AgrC. Mol Microbiol. 2009;74:44-57. [PMID: 19708918 DOI: 10.1111/j.1365-2958.2009.06849.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
188 Saveanu A, Lavaque E, Gunz G, Barlier A, Kim S, Taylor JE, Culler MD, Enjalbert A, Jaquet P. Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells. The Journal of Clinical Endocrinology & Metabolism 2002;87:5545-52. [DOI: 10.1210/jc.2002-020934] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 5.3] [Reference Citation Analysis]
189 Kvols LK, Woltering EA. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors. Anticancer Drugs 2006;17:601-8. [PMID: 16917205 DOI: 10.1097/01.cad.0000210335.95828.ed] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
190 Patel SG, Zhou G, Liu SH, Li M, Jeong JW, DeMayo FJ, Gingras MC, Gibbs RA, Fisher WE, Brunicardi FC. Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas. World J Surg 2009;33:630-7. [PMID: 19137362 DOI: 10.1007/s00268-008-9893-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
191 Liu Q, Reubi J, Wang Y, Knoll BJ, Schonbrunn A. In Vivo Phosphorylation of the Somatostatin 2A Receptor in Human Tumors. The Journal of Clinical Endocrinology & Metabolism 2003;88:6073-9. [DOI: 10.1210/jc.2003-030986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
192 Grant M, Patel RC, Kumar U. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. J Biol Chem 2004;279:38636-43. [PMID: 15247250 DOI: 10.1074/jbc.M406276200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
193 Cuny T, Graillon T, Defilles C, Datta R, Zhang S, Figarella-Branger D, Dufour H, Mougel G, Brue T, Landsman T, Halem HA, Culler MD, Barlier A, Saveanu A. Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells. Pituitary 2021;24:351-8. [PMID: 33433890 DOI: 10.1007/s11102-020-01113-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Wildemberg LE, Neto LV, Costa DF, Nasciuti LE, Takiya CM, Alves LM, Rebora A, Minuto F, Ferone D, Gadelha MR. Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs. J Endocrinol Invest 2013;36:38-43. [PMID: 22472799 DOI: 10.3275/8305] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
195 Kumar SS, Ayuk J, Murray RD. Current therapy and drug pipeline for the treatment of patients with acromegaly. Adv Therapy 2009;26:383-403. [DOI: 10.1007/s12325-009-0029-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
196 Ayoub MA, Levoye A, Delagrange P, Jockers R. Preferential Formation of MT 1 /MT 2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT 2 Homodimers. Mol Pharmacol 2004;66:312-21. [DOI: 10.1124/mol.104.000398] [Cited by in Crossref: 136] [Cited by in F6Publishing: 133] [Article Influence: 8.0] [Reference Citation Analysis]
197 Breit A, Lagacé M, Bouvier M. Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties. Journal of Biological Chemistry 2004;279:28756-65. [DOI: 10.1074/jbc.m313310200] [Cited by in Crossref: 115] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
198 Reubi JC. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy. Endocrine Reviews 2003;24:389-427. [DOI: 10.1210/er.2002-0007] [Cited by in Crossref: 757] [Cited by in F6Publishing: 697] [Article Influence: 151.4] [Reference Citation Analysis]
199 Janson E, Öberg K. Neuroendocrine tumors—somatostatin receptor expression and somatostatin analog treatment. Elsevier; 2003. pp. 535-46. [DOI: 10.1016/s0921-4410(03)21025-5] [Cited by in Crossref: 14] [Article Influence: 0.8] [Reference Citation Analysis]
200 Devi LA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 2001;22:532-7. [PMID: 11583811 DOI: 10.1016/s0165-6147(00)01799-5] [Cited by in Crossref: 214] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
201 Nemoto W, Yamanishi Y, Limviphuvadh V, Saito A, Toh H. GGIP: Structure and sequence-based GPCR-GPCR interaction pair predictor. Proteins 2016;84:1224-33. [PMID: 27191053 DOI: 10.1002/prot.25071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
202 Gatto F, Barbieri F, Arvigo M, Thellung S, Amarù J, Albertelli M, Ferone D, Florio T. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int J Mol Sci 2019;20:E3940. [PMID: 31412614 DOI: 10.3390/ijms20163940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
203 Jiang H, Betancourt L, Smith RG. Ghrelin Amplifies Dopamine Signaling by Cross Talk Involving Formation of Growth Hormone Secretagogue Receptor/Dopamine Receptor Subtype 1 Heterodimers. Molecular Endocrinology 2006;20:1772-85. [DOI: 10.1210/me.2005-0084] [Cited by in Crossref: 185] [Cited by in F6Publishing: 174] [Article Influence: 12.3] [Reference Citation Analysis]
204 Tian R, Jacobson O, Niu G, Kiesewetter DO, Wang Z, Zhu G, Ma Y, Liu G, Chen X. Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy. Theranostics 2018;8:735-45. [PMID: 29344302 DOI: 10.7150/thno.23491] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
205 Joseph IMP, Zavros Y, Merchant JL, Kirschner D. A model for integrative study of human gastric acid secretion. Journal of Applied Physiology 2003;94:1602-18. [DOI: 10.1152/japplphysiol.00281.2002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
206 Lavoie C, Hébert TE. Pharmacological characterization of putative β 12 -adrenergic receptor heterodimers. Can J Physiol Pharmacol 2003;81:186-95. [DOI: 10.1139/y02-167] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
207 Culler M. Evolving concepts in the quest for advanced therapeutic analogues of somatostatin. Digestive and Liver Disease 2004;36:S17-25. [DOI: 10.1016/j.dld.2003.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
208 Haack KKV, Tougas MR, Jones KT, El-dahr SS, Radhakrishna H, Mccarty NA. A Novel Bioassay for Detecting GPCR Heterodimerization: Transactivation of Beta 2 Adrenergic Receptor by Bradykinin Receptor. J Biomol Screen 2010;15:251-60. [DOI: 10.1177/1087057109360254] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
209 Li W, Lin H. The endocrine regulation network of growth hormone synthesis and secretion in fish: Emphasis on the signal integration in somatotropes. Sci China Life Sci 2010;53:462-70. [DOI: 10.1007/s11427-010-0084-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
210 Ke J, Zhong Y. Expression of somatostatin receptor subtype 5 in rat retinal amacrine cells. Neuroscience 2007;144:1025-32. [DOI: 10.1016/j.neuroscience.2006.10.047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
211 van Hulsteijn LT, van Duinen N, Verbist BM, Jansen JC, van der Klaauw AA, Smit JWA, Corssmit EPM, Andersen P. Effects of octreotide therapy in progressive head and neck paragangliomas: Case series: O ctreotide in Head and Neck Paragangliomas. Head Neck 2013;35:E391-6. [DOI: 10.1002/hed.23348] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
212 Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20:255-264. [PMID: 12721505 DOI: 10.1385/ENDO: 20: 3: 255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati L. Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development. J Acupunct Meridian Stud 2009;2:1-25. [PMID: 20633470 DOI: 10.1016/S2005-2901(09)60011-X] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
214 Barki-Harrington L, Bookout AL, Wang G, Lamb ME, Leeb-Lundberg LM, Daaka Y. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J 2003;371:581-7. [PMID: 12534343 DOI: 10.1042/BJ20021708] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
215 Mak SOK, Zhang L, Chow BKC. In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN. FASEB j 2019;33:5389-98. [DOI: 10.1096/fj.201801732rr] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
216 Hanyaloglu AC, Seeber RM, Kohout TA, Lefkowitz RJ, Eidne KA. Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2. J Biol Chem 2002;277:50422-30. [PMID: 12393857 DOI: 10.1074/jbc.M209340200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
217 Floyd DH, Geva A, Bruinsma SP, Overton MC, Blumer KJ, Baranski TJ. C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J Biol Chem 2003;278:35354-61. [PMID: 12835318 DOI: 10.1074/jbc.M305607200] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
218 Watt HL, Kharmate GD, Kumar U. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell Signal. 2009;21:428-439. [PMID: 19070659 DOI: 10.1016/j.cellsig.2008.11.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
219 Milligan G. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology. Mol Pharmacol 2004;66:1-7. [DOI: 10.1124/mol.104.000497] [Cited by in Crossref: 74] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
220 Saveanu A, Jaquet P, Brue T, Barlier A. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas. Mol Cell Endocrinol 2008;286:206-13. [PMID: 18241980 DOI: 10.1016/j.mce.2007.12.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
221 Thomsen W, Behan D. G Protein-Coupled Receptors. Comprehensive Medicinal Chemistry II. Elsevier; 2007. pp. 771-826. [DOI: 10.1016/b0-08-045044-x/00062-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
222 Ludvigsen E, Olsson R, Stridsberg M, Janson ET, Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J Histochem Cytochem 2004;52:391-400. [PMID: 14966206 DOI: 10.1177/002215540405200310] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
223 Cowles RA, Segura BJ, Mulholland MW. Regulation of carbachol-induced c-fos mRNA expression in AR42J cells by somatostatin receptor subtypes 1, 2, and 3. Pancreas. 2002;25:239-244. [PMID: 12370534 DOI: 10.1097/00006676-200210000-00005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
224 Lin X, Peter RE. Somatostatins and their receptors in fish. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2001;129:543-50. [DOI: 10.1016/s1096-4959(01)00362-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
225 Chisholm C, Greenberg GR. Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures. Am J Physiol Endocrinol Metab. 2002;283:E311-E317. [PMID: 12110536 DOI: 10.1152/ajpendo.00434.2001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
226 Kraetke O, Wiesner B, Eichhorst J, Furkert J, Bienert M, Beyermann M. Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J Recept Signal Transduct Res 2005;25:251-76. [PMID: 16393915 DOI: 10.1080/10799890500468838] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
227 Bakker RA, Dees G, Carrillo JJ, Booth RG, López-Gimenez JF, Milligan G, Strange PG, Leurs R. Domain swapping in the human histamine H1 receptor. J Pharmacol Exp Ther 2004;311:131-8. [PMID: 15159444 DOI: 10.1124/jpet.104.067041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
228 Talme T, Sundqvist K. The Effects of Somatostatin on Immune Cells, Functions and Diseases. In: Levite M, editor. Nerve-Driven Immunity. Vienna: Springer; 2012. pp. 203-25. [DOI: 10.1007/978-3-7091-0888-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
229 Terrillon S, Barberis C, Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci U S A 2004;101:1548-53. [PMID: 14757828 DOI: 10.1073/pnas.0305322101] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 6.9] [Reference Citation Analysis]
230 War SA, Kumar U. Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis. J Mol Signal 2012;7:5. [PMID: 22651821 DOI: 10.1186/1750-2187-7-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
231 Lamberts SW, de Herder WW, Hofland LJ. Somatostatin analogs in the diagnosis and treatment of cancer. Trends Endocrinol Metab. 2002;13:451-457. [PMID: 12431842 DOI: 10.1016/s1043-2760(02)00667-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
232 Lahlou H, Guillermet J, Hortala M, Vernejoul F, Pyronnet S, Bousquet C, Susini C. Molecular signaling of somatostatin receptors. Ann N Y Acad Sci. 2004;1014:121-131. [PMID: 15153426 DOI: 10.1196/annals.1294.012] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
233 Castillo-Badillo JA, Cabrera-Wrooman A, García-Sáinz JA. Visualizing G protein-coupled receptors in action through confocal microscopy techniques. Arch Med Res 2014;45:283-93. [PMID: 24751328 DOI: 10.1016/j.arcmed.2014.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
234 Maurel D, Kniazeff J, Mathis G, Trinquet E, Pin J, Ansanay H. Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Analytical Biochemistry 2004;329:253-62. [DOI: 10.1016/j.ab.2004.02.013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 5.4] [Reference Citation Analysis]
235 Cuevas-ramos D, Fleseriu M. Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. Journal of Molecular Endocrinology 2014;52:R223-40. [DOI: 10.1530/jme-14-0011] [Cited by in Crossref: 94] [Cited by in F6Publishing: 51] [Article Influence: 13.4] [Reference Citation Analysis]
236 Oishi A, Cecon E, Jockers R. Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function. G Protein-Coupled Receptors: Emerging Paradigms in Activation, Signaling and Regulation Part A. Elsevier; 2018. pp. 59-77. [DOI: 10.1016/bs.ircmb.2018.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
237 Park PS, Filipek S, Wells JW, Palczewski K. Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 2004;43:15643-56. [PMID: 15595821 DOI: 10.1021/bi047907k] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 10.6] [Reference Citation Analysis]
238 Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20:255-264. [PMID: 12721505 DOI: 10.1385/endo:20:3:255] [Cited by in Crossref: 91] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
239 Sciarra A, Bosman C, Monti G, Gentile V, Gomez AMA, Ciccariello M, Pastore A, Salvatori G, Fattore F, Di Silverio F. SOMATOSTATIN ANALOGUES AND ESTROGENS IN THE TREATMENT OF ANDROGEN ABLATION REFRACTORY PROSTATE ADENOCARCINOMA. Journal of Urology 2004;172:1775-83. [DOI: 10.1097/01.ju.0000140875.07255.f5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
240 Minegishi T, Nakamura K, Yamashita S, Omori Y. The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor. Mol Cell Endocrinol 2007;260-262:117-25. [PMID: 17092637 DOI: 10.1016/j.mce.2005.11.051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
241 Zhou G, Sinnett-Smith J, Liu SH, Yu J, Wu J, Sanchez R, Pandol SJ, Abrol R, Nemunaitis J, Rozengurt E, Brunicardi FC. Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin. Front Physiol 2014;5:226. [PMID: 25009500 DOI: 10.3389/fphys.2014.00226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
242 Gatto F, Hofland LJ. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr Relat Cancer 2011;18:R233-51. [PMID: 22135243 DOI: 10.1530/ERC-10-0334] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
243 Appetecchia M, Baldelli R. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives. J Exp Clin Cancer Res. 2010;29:19. [PMID: 20196864 DOI: 10.1186/1756-9966-29-19] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
244 Gola M, Bonadonna S, Mazziotti G, Amato G, Giustina A. Resistance to somatostatin analogs in acromegaly: an evolving concept? J Endocrinol Invest 2006;29:86-93. [PMID: 16553040 DOI: 10.1007/BF03349183] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
245 Marshall F. Heterodimerization of G-protein-coupled receptors in the CNS. Current Opinion in Pharmacology;1:40-4. [DOI: 10.1016/s1471-4892(01)00001-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
246 Overton MC, Chinault SL, Blumer KJ. Oligomerization of G-protein-coupled receptors: lessons from the yeast Saccharomyces cerevisiae. Eukaryot Cell 2005;4:1963-70. [PMID: 16339714 DOI: 10.1128/EC.4.12.1963-1970.2005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
247 Hofland LJ, Lamberts SWJ. The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance. Endocrine Reviews 2003;24:28-47. [DOI: 10.1210/er.2000-0001] [Cited by in Crossref: 317] [Cited by in F6Publishing: 270] [Article Influence: 63.4] [Reference Citation Analysis]
248 Cuny T, Mohamed A, Graillon T, Roche C, Defilles C, Germanetti AL, Couderc B, Figarella-Branger D, Enjalbert A, Barlier A, Saveanu A. Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. Mol Cell Endocrinol 2012;355:106-13. [PMID: 22348806 DOI: 10.1016/j.mce.2012.01.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
249 Wang XP, Norman MA, Brunicardi FC. Somatostatin receptors and autoimmune-mediated diabetes. Diabetes Metab Res Rev 2005;21:15-30. [PMID: 15624122 DOI: 10.1002/dmrr.531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
250 Milligan G. Oligomerisation of G-protein-coupled receptors. Journal of Cell Science 2001;114:1265-71. [DOI: 10.1242/jcs.114.7.1265] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
251 Kota P, Reeves PJ, Rajbhandary UL, Khorana HG. Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface. Proc Natl Acad Sci U S A 2006;103:3054-9. [PMID: 16492774 DOI: 10.1073/pnas.0510982103] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
252 Culler MD, Oberg K, Arnold R, Krenning EP, Sevilla I, Díaz JA. Somatostatin analogs for the treatment of neuroendocrine tumors. Cancer Metastasis Rev. 2011;30 Suppl 1:9-17. [PMID: 21369878 DOI: 10.1007/s10555-011-9293-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
253 Wang W, Qiao Y, Li Z. New Insights into Modes of GPCR Activation. Trends in Pharmacological Sciences 2018;39:367-86. [DOI: 10.1016/j.tips.2018.01.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 28.7] [Reference Citation Analysis]
254 Park S, Kamegai J, Johnson TA, Frohman LA, Kineman RD. Modulation of Pituitary Somatostatin Receptor Subtype (sst1–5) Messenger Ribonucleic Acid Levels by Changes in the Growth Hormone Axis*. Endocrinology 2000;141:3556-63. [DOI: 10.1210/endo.141.10.7727] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
255 Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep 2004;5:30-4. [PMID: 14710183 DOI: 10.1038/sj.embor.7400052] [Cited by in Crossref: 469] [Cited by in F6Publishing: 433] [Article Influence: 27.6] [Reference Citation Analysis]
256 Planes N, Digman MA, Vanderheyden PP, Gratton E, Caballero-george C. Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT1 and the endothelin-1 ETA receptors: Influence of ligand binding. Biochimica et Biophysica Acta (BBA) - General Subjects 2019;1863:917-24. [DOI: 10.1016/j.bbagen.2019.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
257 Tian H, Fürstenberg A, Huber T. Labeling and Single-Molecule Methods To Monitor G Protein-Coupled Receptor Dynamics. Chem Rev 2017;117:186-245. [DOI: 10.1021/acs.chemrev.6b00084] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
258 Reggio PH. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J 2006;8:E322-36. [PMID: 16796383 DOI: 10.1007/BF02854903] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
259 Marazuela M, Ramos-leví AM, Borges de Souza P, Zatelli MC. Is receptor profiling useful for predicting pituitary therapy? European Journal of Endocrinology 2018;179:D15-25. [DOI: 10.1530/eje-18-0549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
260 Baragli A, Alturaihi H, Watt HL, Abdallah A, Kumar U. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 2007;19:2304-16. [PMID: 17706924 DOI: 10.1016/j.cellsig.2007.07.007] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
261 Miret JJ, Rakhilina L, Silverman L, Oehlen B. Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast. J Biol Chem 2002;277:6881-7. [PMID: 11733510 DOI: 10.1074/jbc.M107384200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
262 Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 2001;98:343-8. [PMID: 11134510 DOI: 10.1073/pnas.011384898] [Cited by in Crossref: 76] [Cited by in F6Publishing: 134] [Article Influence: 3.8] [Reference Citation Analysis]
263 Smyth EM, FitzGerald GA. Human prostacyclin receptor. Vitam Horm 2002;65:149-65. [PMID: 12481546 DOI: 10.1016/s0083-6729(02)65063-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
264 Szafran K, Faron-Górecka A, Kolasa M, Kuśmider M, Solich J, Zurawek D, Dziedzicka-Wasylewska M. Potential role of G protein-coupled receptor (GPCR) heterodimerization in neuropsychiatric disorders: a focus on depression. Pharmacol Rep 2013;65:1498-505. [PMID: 24552997 DOI: 10.1016/s1734-1140(13)71510-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
265 Kumar U. Cross-talk and modulation of signaling between somatostatin and growth factor receptors. Endocrine 2011;40:168-80. [PMID: 21870170 DOI: 10.1007/s12020-011-9524-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
266 Ramírez JL, Gracia-Navarro F, García-Navarro S, Torronteras R, Malagón MM, Castaño JP. Somatostatin stimulates GH secretion in two porcine somatotrope subpopulations through a cAMP-dependent pathway. Endocrinology 2002;143:889-97. [PMID: 11861510 DOI: 10.1210/endo.143.3.8685] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
267 Horuk R, Salamon H, Lu H. The biology and physiology of somatostatin receptors. Expert Opinion on Therapeutic Targets 2005;5:613-23. [DOI: 10.1517/14728222.5.5.613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
268 War SA, Somvanshi RK, Kumar U. Somatostatin receptor-3 mediated intracellular signaling and apoptosis is regulated by its cytoplasmic terminal. Biochim Biophys Acta 2011;1813:390-402. [PMID: 21194548 DOI: 10.1016/j.bbamcr.2010.12.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
269 Brady AE, Limbird LE. G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction. Cellular Signalling 2002;14:297-309. [DOI: 10.1016/s0898-6568(01)00239-x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 59] [Article Influence: 10.0] [Reference Citation Analysis]
270 Saveanu A, Jaquet P. Somatostatin–dopamine ligands in the treatment of pituitary adenomas. Rev Endocr Metab Disord 2009;10:83-90. [DOI: 10.1007/s11154-008-9086-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
271 Shimon I, Rubinek T, Hadani M, Alhadef N. PTR-3173 (Somatoprim™), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion. J Endocrinol Invest 2004;27:721-7. [DOI: 10.1007/bf03347512] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
272 Stengel A, Taché YF. Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response. Front Neurosci 2017;11:231. [PMID: 28487631 DOI: 10.3389/fnins.2017.00231] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
273 Ng HK, Chow BK. Oligomerization of Family B GPCRs: Exploration in Inter-Family Oligomer Formation. Front Endocrinol (Lausanne) 2015;6:10. [PMID: 25699019 DOI: 10.3389/fendo.2015.00010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
274 Kharmate G, Rajput PS, Watt HL, Somvanshi RK, Chaudhari N, Qiu X, Kumar U. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011;1813:1172-89. [DOI: 10.1016/j.bbamcr.2011.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
275 Yoshioka K, Saitoh O, Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci U S A 2001;98:7617-22. [PMID: 11390975 DOI: 10.1073/pnas.121587098] [Cited by in Crossref: 182] [Cited by in F6Publishing: 174] [Article Influence: 9.1] [Reference Citation Analysis]
276 Park PS, Sum CS, Pawagi AB, Wells JW. Cooperativity and Oligomeric Status of Cardiac Muscarinic Cholinergic Receptors. Biochemistry 2002;41:5588-604. [DOI: 10.1021/bi011746s] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
277 Filizola M, Guo W, Javitch JA, Weinstein H. Oligomerization Domains of G Protein-Coupled Receptors. In: Devi LA, editor. The G Protein-Coupled Receptors Handbook. Totowa: Humana Press; 2005. pp. 243-65. [DOI: 10.1007/978-1-59259-919-6_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Filizola M, Olmea O, Weinstein H. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Engineering, Design and Selection 2002;15:881-5. [DOI: 10.1093/protein/15.11.881] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 3.8] [Reference Citation Analysis]
279 Watt HL, Kumar U. Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells. Cancer Cell Int 2006;6:5. [PMID: 16519802 DOI: 10.1186/1475-2867-6-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
280 Meyer BH, Segura JM, Martinez KL, Hovius R, George N, Johnsson K, Vogel H. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci U S A 2006;103:2138-43. [PMID: 16461466 DOI: 10.1073/pnas.0507686103] [Cited by in Crossref: 177] [Cited by in F6Publishing: 169] [Article Influence: 11.8] [Reference Citation Analysis]
281 Kyriakakis N, Seejore K, Hanafy A, Murray RD. Management of persistent acromegaly following primary therapy: The current landscape in the UK. Endocrinol Diabetes Metab 2020;3:e00158. [PMID: 32704572 DOI: 10.1002/edm2.158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Margeta-mitrovic M. Assembly-dependent trafficking assays in the detection of receptor–receptor interactions. Methods 2002;27:311-7. [DOI: 10.1016/s1046-2023(02)00088-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
283 Mazziotti G, Mosca A, Frara S, Vitale G, Giustina A. Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects. Expert Opin Pharmacother. 2017;18:1679-1689. [PMID: 29067877 DOI: 10.1080/14656566.2017.1391217] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
284 Albertelli M, Arvigo M, Boschetti M, Ferone D, Gatto F, Minuto F. Somatostatin receptor pathophysiology in the neuroendocrine system. Expert Rev Endocrinol Metab 2013;8:149-57. [PMID: 30736175 DOI: 10.1586/eem.13.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Cheng ZJ, Miller LJ. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001;276:48040-7. [PMID: 11673456 DOI: 10.1074/jbc.M105668200] [Cited by in Crossref: 95] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
286 Khan MS, Caplin ME. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2011;18 Suppl 1:S53-74. [PMID: 22005115 DOI: 10.1530/ERC-10-0271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
287 Zhu C, Cook LB, Hinkle PM. Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation. Journal of Biological Chemistry 2002;277:28228-37. [DOI: 10.1074/jbc.m204221200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
288 Otmakhova NA, Lewey J, Asrican B, Lisman JE. Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline. J Neurophysiol 2005;94:1413-22. [PMID: 15888529 DOI: 10.1152/jn.00217.2005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
289 Somvanshi RK, War SA, Chaudhari N, Qiu X, Kumar U. Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5. Cell Signal 2011;23:794-811. [PMID: 21238583 DOI: 10.1016/j.cellsig.2011.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
290 Ben-Shlomo A, Pichurin O, Barshop NJ, Wawrowsky KA, Taylor J, Culler MD, Chesnokova V, Liu NA, Melmed S. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation. Mol Endocrinol 2007;21:2565-78. [PMID: 17609435 DOI: 10.1210/me.2007-0081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
291 Eidne KA, Kroeger KM, Hanyaloglu AC. Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends Endocrinol Metab 2002;13:415-21. [PMID: 12431837 DOI: 10.1016/s1043-2760(02)00669-0] [Cited by in Crossref: 80] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
292 Nelson LE, Sheridan MA. Regulation of somatostatins and their receptors in fish. General and Comparative Endocrinology 2005;142:117-33. [DOI: 10.1016/j.ygcen.2004.12.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
293 Cuny T, Gerard C, Saveanu A, Barlier A, Enjalbert A. Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy. Ann N Y Acad Sci 2011;1220:60-70. [PMID: 21388404 DOI: 10.1111/j.1749-6632.2010.05924.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
294 Milligan G, Lopez-gimenez J, Wilson S, Carrillo JJ. Selectivity in the oligomerisation of G protein-coupled receptors. Seminars in Cell & Developmental Biology 2004;15:263-8. [DOI: 10.1016/j.semcdb.2003.12.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
295 Schonenbach NS, Hussain S, O'malley MA. Structure and function of G protein‐coupled receptor oligomers: implications for drug discovery. WIREs Nanomed Nanobiotechnol 2015;7:408-27. [DOI: 10.1002/wnan.1319] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
296 Pfleger KD, Eidne KA. Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. Biochem J 2005;385:625-37. [PMID: 15504107 DOI: 10.1042/BJ20041361] [Cited by in Crossref: 118] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
297 Overton MC, Blumer KJ. Use of fluorescence resonance energy transfer to analyze oligomerization of G-protein-coupled receptors expressed in yeast. Methods 2002;27:324-32. [DOI: 10.1016/s1046-2023(02)00090-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
298 Woolf PJ, Linderman JJ. An algebra of dimerization and its implications for G-protein coupled receptor signaling. J Theor Biol 2004;229:157-68. [PMID: 15207471 DOI: 10.1016/j.jtbi.2004.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
299 Grant M, Kumar U. The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5. Regulatory Peptides 2010;159:3-8. [DOI: 10.1016/j.regpep.2009.08.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
300 Sud D, Joseph IMP, Kirschner D. PREDICTING EFFICACY OF PROTON PUMP INHIBITORS IN REGULATING GASTRIC ACID SECRETION. J Biol Syst 2011;12:1-34. [DOI: 10.1142/s0218339004000999] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
301 Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 2004;101:5135-9. [PMID: 15044695 DOI: 10.1073/pnas.0307601101] [Cited by in Crossref: 294] [Cited by in F6Publishing: 289] [Article Influence: 17.3] [Reference Citation Analysis]
302 Tirone TA, Norman MA, Moldovan S, DeMayo FJ, Wang XP, Brunicardi FC. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model. Pancreas. 2003;26:e67-e73. [PMID: 12657967 DOI: 10.1097/00006676-200304000-00025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
303 Cattaneo MG, Taylor JE, Culler MD, Nisoli E, Vicentini LM. Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells. FEBS Lett 2000;481:271-6. [PMID: 11007977 DOI: 10.1016/s0014-5793(00)02012-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
304 Kumar U, Baragli A, Patel RC. Probing molecular interactions in single and live cells with fluorescence spectroscopy. TrAC Trends in Analytical Chemistry 2003;22:537-43. [DOI: 10.1016/s0165-9936(03)00601-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
305 Ciganoka D, Balcere I, Kapa I, Peculis R, Valtere A, Nikitina-Zake L, Lase I, Schiöth HB, Pirags V, Klovins J. Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly. Eur J Endocrinol 2011;165:517-25. [PMID: 21810856 DOI: 10.1530/EJE-11-0416] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
306 Alonso N, Fernandez N, Notcovich C, Monczor F, Simaan M, Baldi A, Gutkind JS, Davio C, Shayo C. Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration. Mol Pharmacol 2013;83:1087-98. [PMID: 23462507 DOI: 10.1124/mol.112.083394] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
307 Yim CB, van der Wildt B, Dijkgraaf I, Joosten L, Eek A, Versluis C, Rijkers DT, Boerman OC, Liskamp RM. Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method. Chembiochem 2011;12:750-60. [PMID: 21328514 DOI: 10.1002/cbic.201000639] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
308 Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 2002;277:21522-8. [PMID: 11940583 DOI: 10.1074/jbc.M200729200] [Cited by in Crossref: 224] [Cited by in F6Publishing: 74] [Article Influence: 11.8] [Reference Citation Analysis]
309 Watt HL, Kharmate G, Kumar U. Biology of somatostatin in breast cancer. Mol Cell Endocrinol 2008;286:251-61. [PMID: 18308465 DOI: 10.1016/j.mce.2008.01.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
310 Wessendorf MW, Dooyema J. Coexistence of kappa- and delta-opioid receptors in rat spinal cord axons. Neuroscience Letters 2001;298:151-4. [DOI: 10.1016/s0304-3940(00)01700-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
311 Schöneberg T, Schulz A, Gudermann T. The structural basis of g-protein-coupled receptor function and dysfunction in human diseases. Reviews of Physiology, Biochemistry and Pharmacology. Berlin: Springer Berlin Heidelberg; 2002. pp. 144-227. [DOI: 10.1007/bfb0116587] [Cited by in Crossref: 6] [Reference Citation Analysis]
312 Böhme I, Stichel J, Walther C, Mörl K, Beck-sickinger AG. Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus. Cellular Signalling 2008;20:1740-9. [DOI: 10.1016/j.cellsig.2008.05.017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
313 Spier AD, Fabre V, de Lecea L. Cortistatin radioligand binding in wild-type and somatostatin receptor-deficient mouse brain. Regulatory Peptides 2005;124:179-86. [DOI: 10.1016/j.regpep.2004.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
314 Ludvigsen E, Stridsberg M, Taylor JE, Culler MD, Oberg K, Janson ET. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med Oncol 2004;21:285-95. [PMID: 15456957 DOI: 10.1385/MO:21:3:285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
315 Tovo-Rodrigues L, Roux A, Hutz MH, Rohde LA, Woods AS. Functional characterization of G-protein-coupled receptors: a bioinformatics approach. Neuroscience 2014;277:764-79. [PMID: 24997265 DOI: 10.1016/j.neuroscience.2014.06.049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
316 Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G, Guidolin D, Diaz-cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J, Tanganelli S, Lluis C, Ferré S, Woods A, Franco R, Agnati LF. Intramembrane receptor–receptor interactions: a novel principle in molecular medicine. J Neural Transm 2007;114:49-75. [DOI: 10.1007/s00702-006-0589-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 5.8] [Reference Citation Analysis]
317 Harrison C, van der Graaf PH. Current methods used to investigate G protein coupled receptor oligomerisation. Journal of Pharmacological and Toxicological Methods 2006;54:26-35. [DOI: 10.1016/j.vascn.2005.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
318 Ramsay D, Kellett E, McVey M, Rees S, Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 2002;365:429-40. [PMID: 11971762 DOI: 10.1042/BJ20020251] [Cited by in Crossref: 162] [Cited by in F6Publishing: 126] [Article Influence: 8.5] [Reference Citation Analysis]
319 Theodoropoulou M, Stalla GK. Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol 2013;34:228-52. [PMID: 23872332 DOI: 10.1016/j.yfrne.2013.07.005] [Cited by in Crossref: 170] [Cited by in F6Publishing: 152] [Article Influence: 21.3] [Reference Citation Analysis]
320 Nemoto W, Toh H. Prediction of interfaces for oligomerizations of G-protein coupled receptors. Proteins 2005;58:644-60. [DOI: 10.1002/prot.20332] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
321 Tadavarty R, Rajput PS, Wong JM, Kumar U, Sastry BR. Sleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression. PLoS One 2011;6:e24933. [PMID: 21980366 DOI: 10.1371/journal.pone.0024933] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
322 Volante M, Bozzalla-Cassione F, Papotti M. Somato-statin receptors and their interest in diagnostic pathology. Endocr Pathol. 2004;15:275-291. [PMID: 15681851 DOI: 10.1385/EP:15:4:275] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
323 van der Hoek J, Lamberts SW, Hofland LJ. The somatostatin receptor subtype 5 in neuroendocrine tumours. Expert Opin Investig Drugs 2010;19:385-99. [PMID: 20151855 DOI: 10.1517/13543781003604710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
324 Dai SS, Wang H, Yang N, An JH, Li W, Ning YL, Zhu PF, Chen JF, Zhou YG. Plasma glutamate-modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury. J Exp Med 2013;210:839-51. [PMID: 23478188 DOI: 10.1084/jem.20122196] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
325 Sharma N, Hewett J, Ozelius LJ, Ramesh V, McLean PJ, Breakefield XO, Hyman BT. A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. Am J Pathol 2001;159:339-44. [PMID: 11438481 DOI: 10.1016/s0002-9440(10)61700-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
326 Law P, Erickson-herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, Loh HH. Heterodimerization of μ- and δ-Opioid Receptors Occurs at the Cell Surface Only and Requires Receptor-G Protein Interactions. Journal of Biological Chemistry 2005;280:11152-64. [DOI: 10.1074/jbc.m500171200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
327 Moncayo R. Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis. EJNMMI Res 2011;1:9. [PMID: 22214590 DOI: 10.1186/2191-219X-1-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
328 Curt?? L, Ruggeri RM, Ferone D, Pivonello R, Squadrito S, Campenn?? A, Trovato M, Baldari S, Hofland LJ, Trimarchi F, Cannav?? S. Lack of Somatostatin Analogs Effectiveness in Gonadotropin-Secreting Pituitary Adenomas: Report of a Case and Review of the Literature. The Endocrinologist 2006;16:208-13. [DOI: 10.1097/01.ten.0000225990.98873.cd] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
329 Segond von Banchet G. Somatostatin – ein wichtiger Hemmer neuronaler Erregung. Schmerz 2008;22:409-14. [DOI: 10.1007/s00482-008-0641-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
330 Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(24): 2963-2970 [PMID: 20572298 DOI: 10.3748/wjg.v16.i24.2963] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 63] [Article Influence: 6.5] [Reference Citation Analysis]
331 Bai M. Dimerization of G-protein-coupled receptors: roles in signal transduction. Cellular Signalling 2004;16:175-86. [DOI: 10.1016/s0898-6568(03)00128-1] [Cited by in Crossref: 125] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
332 Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Drugs 2019;79:21-42. [PMID: 30560479 DOI: 10.1007/s40265-018-1033-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
333 Ferone D, Saveanu A, Culler MD, Arvigo M, Rebora A, Gatto F, Minuto F, Jaquet P. Novel chimeric somatostatin analogs: facts and perspectives. Eur J Endocrinol. 2007;156 Suppl 1:S23-S28. [PMID: 17413184 DOI: 10.1530/eje.1.02356] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
334 Lania A, Mantovani G, Spada A. Genetic abnormalities of somatostatin receptors in pituitary tumors. Mol Cell Endocrinol 2008;286:180-6. [PMID: 17913341 DOI: 10.1016/j.mce.2007.08.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
335 Cervia D, Zizzari P, Pavan B, Schuepbach E, Langenegger D, Hoyer D, Biondi C, Epelbaum J, Bagnoli P. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1–sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology 2003;44:672-85. [DOI: 10.1016/s0028-3908(03)00031-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
336 Jaquet P, Gunz G, Saveanu A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Enjalbert A, Culler MD. Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy. Eur J Endocrinol 2005;153:135-41. [PMID: 15994755 DOI: 10.1530/eje.1.01950] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 5.9] [Reference Citation Analysis]
337 Dinger MC, Bader JE, Kóbor AD, Kretzschmar AK, Beck-sickinger AG. Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells. Journal of Biological Chemistry 2003;278:10562-71. [DOI: 10.1074/jbc.m205747200] [Cited by in Crossref: 97] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
338 Gugger M, Reubi JC. Somatostatin. Handbook of Biologically Active Peptides. Elsevier; 2006. pp. 1123-30. [DOI: 10.1016/b978-012369442-3/50157-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
339 Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, Hendy GN. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Human Molecular Genetics 2006;15:2200-9. [DOI: 10.1093/hmg/ddl145] [Cited by in Crossref: 104] [Cited by in F6Publishing: 80] [Article Influence: 6.9] [Reference Citation Analysis]
340 Blanpain C, Vanderwinden JM, Cihak J, Wittamer V, Le Poul E, Issafras H, Stangassinger M, Vassart G, Marullo S, Schlndorff D, Parmentier M, Mack M. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol Biol Cell 2002;13:723-37. [PMID: 11854425 DOI: 10.1091/mbc.01-03-0129] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
341 Yamashita S, Nakamura K, Omori Y, Tsunekawa K, Murakami M, Minegishi T. Association of human follitropin (FSH) receptor with splicing variant of human lutropin/choriogonadotropin receptor negatively controls the expression of human FSH receptor. Mol Endocrinol 2005;19:2099-111. [PMID: 15890674 DOI: 10.1210/me.2005-0049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
342 Cammalleri M, Cervia D, Langenegger D, Liu Y, Dal Monte M, Hoyer D, Bagnoli P. Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices. Eur J Neurosci 2004;20:2711-21. [PMID: 15548214 DOI: 10.1111/j.1460-9568.2004.03741.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
343 Mousavi SA, Malerod L, Berg T, Kjeken R. Clathrin-dependent endocytosis. Biochem J. 2004;377:1-16. [PMID: 14505490 DOI: 10.1042/bj20031000] [Cited by in Crossref: 236] [Cited by in F6Publishing: 218] [Article Influence: 13.9] [Reference Citation Analysis]
344 Saha S, Henderson Z, Batten TF. Somatostatin immunoreactivity in axon terminals in rat nucleus tractus solitarii arising from central nucleus of amygdala: coexistence with GABA and postsynaptic expression of sst2A receptor. J Chem Neuroanat 2002;24:1-13. [PMID: 12084407 DOI: 10.1016/s0891-0618(02)00013-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
345 Wang CH, Tang CW, Liu CL, Tang LP. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9(9): 1904-1908 [PMID: 12970873 DOI: 10.3748/wjg.v9.i9.1904] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
346 Somvanshi RK, Kumar U. Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors. Pharmaceuticals (Basel) 2012;5:417-46. [PMID: 24281555 DOI: 10.3390/ph5050417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
347 Meng F, Huang G, Gao S, Li J, Yan Z, Wang Y. Identification of the receptors for somatostatin (SST) and cortistatin (CST) in chickens and investigation of the roles of cSST28, cSST14, and cCST14 in inhibiting cGHRH1–27NH2-induced growth hormone secretion in cultured chicken pituitary cells. Molecular and Cellular Endocrinology 2014;384:83-95. [DOI: 10.1016/j.mce.2014.01.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
348 Grünewald S, Schupp BJ, Ikeda SR, Kuner R, Steigerwald F, Kornau HC, Köhr G. Importance of the gamma-aminobutyric acid(B) receptor C-termini for G-protein coupling. Mol Pharmacol 2002;61:1070-80. [PMID: 11961124 DOI: 10.1124/mol.61.5.1070] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
349 Volante M, Rosas R, Allìa E, Granata R, Baragli A, Muccioli G, Papotti M. Somatostatin, cortistatin and their receptors in tumours. Mol Cell Endocrinol. 2008;286:219-229. [PMID: 18248880 DOI: 10.1016/j.mce.2007.12.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
350 Wurch T, Matsumoto A, Pauwels P. Agonist-independent and -dependent oligomerization of dopamine D 2 receptors by fusion to fluorescent proteins. FEBS Letters 2001;507:109-13. [DOI: 10.1016/s0014-5793(01)02969-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]